NEK2 and breast carcinoma: Previous studies have also shown that CD4+ T cells significantly inhibit tumor development [141], neutrophils [142,143,144], and DCs [145,146,147,148], and our study also revealed correlations of the NEK2 gene with several immune infiltration rate algorithms in breast cancer tissues.